Cited by 934Cancer Cells and MetastasisDevelopmental Biology and Gene RegulationColorectal Cancer Treatments and Studies

The Intestinal Stem Cell Signature Identifies Colorectal Cancer Stem Cells and Predicts Disease Relapse

Open access
Merlos-Suárez, Anna, Barriga, Francisco M., Jung, Peter, Iglesias, Mar, Céspedes, María Virtudes, Rossell, David, Sevillano, Marta, Hernando-Momblona, Xavier +6 more·2011·Cell Stem Cell

Abstract

A frequent complication in colorectal cancer (CRC) is regeneration of the tumor after therapy. Here, we report that a gene signature specific for adult intestinal stem cells (ISCs) predicts disease relapse in CRC patients. ISCs are marked by high expression of the EphB2 receptor, which becomes gradually silenced as cells differentiate. Using EphB2 and the ISC marker Lgr5, we have FACS-purified and profiled mouse ISCs, crypt proliferative progenitors, and late transient amplifying cells to define a gene program specific for normal ISCs. Furthermore, we discovered that ISC-specific genes identify a stem-like cell population positioned at the bottom of tumor structures reminiscent of crypts. EphB2 sorted ISC-like tumor cells display robust tumor-initiating capacity in immunodeficient mice as well as long-term self-renewal potential. Taken together, our data suggest that the ISC program defines a cancer stem cell niche within colorectal tumors and plays a central role in CRC relapse.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.stem.2011.02.020

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Merlos-Suárez, A., Barriga, F. M., Jung, P., Iglesias, M., Céspedes, M. V., Rossell, D., Sevillano, M., Hernando-Momblona, X., da Silva-Diz, V., Muñoz, P., Clevers, H., Sancho, E., Mangues, R., & Batlle, E.
Affiliations
  • Institute for Research in Biomedicine (ES)
  • Universitat Autònoma de Barcelona (ES)
  • Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (ES)
  • University Medical Center Utrecht (NL)
  • Institució Catalana de Recerca i Estudis Avançats (ES)
Corresponding author
Batlle, Eduard
Venue
Cell Stem Cell
Publisher
Elsevier BV
Published
2011-05
Volume
8
Issue
5
Pages
511-524
ISSN
  • 1875-9777 (ISSN-L)
  • 1934-5909
OpenAlex
W2157910818
Cited by
934
References
43
Citations by year
2026: 24 · 2025: 38 · 2024: 46 · 2023: 59 · 2022: 67 · 2021: 65 · 2020: 70 · 2019: 64 · 2018: 76 · 2017: 70 · 2016: 67 · 2015: 85 · 2014: 65 · 2013: 62 · 2012: 56
FWCI
31.56
Type
journal article
Language
en
Open access
Locations
  • Cell stem cell (publishedVersion)
  • PubMed (publishedVersion)
  • KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (publishedVersion)
  • RECERCAT (Consorci de Serveis Universitaris de Catalunya) (publishedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion, other-oa)
Funders
Genentech
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
Keywords
colorectal cancer, cancer stem cells, intestinal stem cells, EphB2, Lgr5, gene expression signatures, recurrence, transit amplifying cells, tumor-initiating capacity, self-renewal, stem cell niche
MeSH terms
Animals, Cell Differentiation, Cell Separation, Cells, Cultured, Colonic Neoplasms, Flow Cytometry, Humans, Intestines, Neoplasm Recurrence, Local, Prognosis, Neoplastic Stem Cells, Mice, Knockout, Gene Expression Regulation, Developmental, Gene Expression Profiling, Cell Surface Extensions, Receptor, EphB3, Receptors, G-Protein-Coupled, Mice, Adult Stem Cells, Stem Cell Niche

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review